Gene Expression of CXCL1 (GRO-α) and EGF by Platelets in Myeloproliferative Neoplasms

Gene Expression of CXCL1 (GRO-α) and EGF by Platelets in Myeloproliferative Neoplasms

Bibliographic Details
Main Authors:	Ryan J. Collinson, Allegra Mazza-Parton, Kathryn A. Fuller, Matthew D. Linden, Wendy N. Erber, Belinda B. Guo
Format:	Article
Language:	English
Published:	Wolters Kluwer 2020-12-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000490

Similar Items

Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms
by: Cecilia P. Marin Oyarzún, et al.
Published: (2019-06-01)

Aetiology of Myeloproliferative Neoplasms
by: Mary Frances McMullin, et al.
Published: (2020-07-01)

To study the role of CXCL1/GROα induced by ENPEP in regulating migration of colon cancer
by: Ya-Jun Wu, et al.
Published: (2013)

Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
by: Marion Divoux, et al.
Published: (2020-09-01)

Longitudinal Cytokine Profiling Identifies GRO-α and EGF as Potential Biomarkers of Disease Progression in Essential Thrombocythemia
by: Nina F. Øbro, et al.
Published: (2020-06-01)

Molecular pathogenesis of the myeloproliferative neoplasms
by: Graeme Greenfield, et al.
Published: (2021-06-01)

Targeted therapies for myeloproliferative neoplasms
by: Bing Li, et al.
Published: (2019-07-01)

Novel therapeutics in myeloproliferative neoplasms
by: Sangeetha Venugopal, et al.
Published: (2020-12-01)

Mutant Calreticulin in the Myeloproliferative Neoplasms
by: Daniel Prins, et al.
Published: (2020-02-01)

Neurological Findings in Myeloproliferative Neoplasms
by: Semra Paydas
Published: (2013-04-01)

Experimental Modeling of Myeloproliferative Neoplasms
by: Lucie Lanikova, et al.
Published: (2019-10-01)

Calreticulin Mutations in Myeloproliferative Neoplasms
by: Noa Lavi
Published: (2014-10-01)

CALR Mutations in Myeloproliferative Neoplasms
by: Ken-Hong Lim
Published: (2014-06-01)

The Hematopoietic Niche in Myeloproliferative Neoplasms
by: Annette H. Schmitt-Graeff, et al.
Published: (2015-01-01)

The Roles of Calreticulin Mutations in Myeloproliferative Neoplasms
by: Ken-Hong Lim, et al.
Published: (2017)

Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
by: Lasse Kjær
Published: (2020-07-01)

Cytokines frequently implicated in myeloproliferative neoplasms
by: Yingying Wang, et al.
Published: (2019-03-01)

Philadelphia-negative chronic myeloproliferative neoplasms
by: Rosane Isabel Bittencourt, et al.
Published: (2012-01-01)

The Role of New Technologies in Myeloproliferative Neoplasms
by: Giuseppe A. Palumbo, et al.
Published: (2019-04-01)

NK Cells in Myeloproliferative Neoplasms (MPN)
by: Erin Naismith, et al.
Published: (2021-08-01)

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
by: Laura Palomo, et al.
Published: (2021-04-01)

Functional Consequences of Mutations in Myeloproliferative Neoplasms
by: Stefan N. Constantinescu, et al.
Published: (2021-06-01)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
by: Ziqi Wan, et al.
Published: (2020-10-01)

Enhanced Platelet Activity May Increase The Risk of Myocardial Infarction and Stroke in Patients with Chronic Myeloproliferative Neoplasms
by: Viola Maria Popov, et al.
Published: (2014-08-01)

The 2020 revision of the guidelines for the management of myeloproliferative neoplasms
by: Sung-Yong Kim, et al.
Published: (2021-01-01)

Challenges and Perspectives for Therapeutic Targeting of Myeloproliferative Neoplasms
by: Sime Brkic, et al.
Published: (2021-01-01)

Evaluation of Common Genetic Disorders in Myeloproliferative Neoplasms
by: Mehrdad Payandeh, et al.
Published: (2011-09-01)

Metabolic Vulnerabilities and Epigenetic Dysregulation in Myeloproliferative Neoplasms
by: Vasundhara Sharma, et al.
Published: (2020-11-01)

Evaluation of Common Genetic Disorders in Myeloproliferative Neoplasms
by: Hoshang Yousefi, et al.
Published: (2011-10-01)

Chronic Myeloproliferative Neoplasms: Some Remaining Challenges
by: Tariq I. Mughal, et al.
Published: (2018-10-01)

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
by: Paola Guglielmelli, et al.
Published: (2010-05-01)

Incidence of myeloproliferative neoplasms in Calgary, Alberta, Canada
by: Jonathan Heppner, et al.
Published: (2019-05-01)

Diagnosis and Treatment of Clonal Myeloproliferative Neoplasms with Eosinophilia
by: IS Nemchenko, et al.
Published: (2019-03-01)

Defining the Thrombotic Risk in Patients with Myeloproliferative Neoplasms
by: Fabrizio Vianello, et al.
Published: (2011-01-01)

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
by: Amandeep Aujla, et al.
Published: (2018-09-01)

The epidemiology and clinical characteristics of myeloproliferative neoplasms in Malaysia
by: Yee Yee Yap, et al.
Published: (2018-12-01)

Arterial and Venous Thrombosis in Patients with Myeloproliferative Neoplasms
by: Lugyanti Sukrisman
Published: (2019-09-01)

Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development
by: Holly L. Geyer, et al.
Published: (2015-01-01)

Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art
by: Sylvie Hermouet, et al.
Published: (2015-01-01)

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
by: Lisa Pieri, et al.
Published: (2010-06-01)

Cannot write session to /tmp/vufind_sessions/sess_0pkvt7es0gf4us32nlpdodqqru